Form 4: Harvard Bioscience Director Acquires Stock Units

Harvard Bioscience, Inc. reports a Form 4 filing detailing the acquisition of restricted stock units by Director Seth Benson.

Summary

• Director Seth Benson was awarded 16,556 restricted stock units (RSUs) on June 9, 2026.
• These RSUs vest in full either immediately prior to the company's next annual meeting or one year from the grant date, whichever comes first.
• Following this award, Benson beneficially owns a total of 27,556 shares of common stock.
• This total includes the newly awarded RSUs and 11,000 previously held shares.
• The filing notes a 10-for-1 reverse stock split that occurred on March 13, 2026, which adjusted previously reported share counts.
• The 11,000 shares referenced were previously reported as 110,000 restricted stock units.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a routine stock award to a director rather than a significant financial event or strategic shift.

Positives

• Director Seth Benson received a significant award of 16,556 restricted stock units, indicating continued alignment with company performance.
• The total beneficial ownership of 27,556 shares by a director demonstrates a vested interest in the company's success.

Future Outlook

The restricted stock units awarded to Seth Benson will vest in full either immediately prior to the company's next annual meeting or one year from the grant date, whichever occurs earlier.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions, providing transparency into the holdings and equity-based compensation of company directors and officers. This filing specifically details an RSU award, a common form of executive compensation designed to incentivize long-term performance.

Stakeholder Impact

• Shareholders gain insight into director compensation and ownership, reinforcing transparency.
• Employees may view the stock award as a positive sign of management's commitment and alignment with long-term value creation.

Next Steps

• Vesting of the 16,556 restricted stock units awarded to Seth Benson.

Key Dates

Keywords

Form 4, SEC Filing, Harvard Bioscience, HBIO, Seth Benson, Director, Stock Award, Restricted Stock Units, Beneficial Ownership, Reverse Stock Split